Sclerosing solutions

The Vein Book

Volumn , Issue , 2007, Pages 125-131

  Feied, Craig ^a  

^a American Vein Institute   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 77955533040     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1016/B978-012369515-4/50016-8     Document Type: Chapter

References (30)

1. Green D Compression sclerotherapy techniques. Dermatol Clin. 1989, 7:137.
2. Fegan WG Varicose veins: Compression sclerotherapy 1967, Heinemann, London.
3. Hanschell HM Treatment of varicose veins. Br Med J. 1947, 2:630.
4. Imhoff E, Stemmer R Classification and mechanism of action of sclerosing agents. Soc Fran Phlebol. 1969, 22:143.
5. Cooper WM. Clinical evaluation of sotradecol, a sodium alkyl sulfate solution in the injection therapy of varicose veins, Surg Gynecol Obstet.
6. MacGowen WAL, et al. The local effects of intra-arterial injections of sodium tetradecyl sulfate (STD) 3%: An experimental study. Br J Surg. 1972, 59:101-104.
7. Dastain JY Sclerotherapy of varices when the patient is on anticoagulants, with reference to 2 patients on anticoagulants. Phlebologie. 1981, 34:73.
8. Kanter AH Complications of sotradecol sclerotherapy with and without heparin. Phlebologie '92 1992, John Libbey Eurotext. P. Raymond-Martimbeau, R. Prescott, M. Zummo (Eds.).
9. Guex JJ MD, Allaert FA, Gillet JL, Chleir F Immediate and mid-term complications of sclerotherapy. Report of a prospective Multi-center registry of 12, 173 sclerotherapy sessions. Dermatol Surg. 2005, 31:123-128.
10. Fegan WG Continuous compression technique of injecting varicose veins. Lancet. 1963, 2:109.
11. Schmier AA Clinical comparison of sclerosing solutions in injection treat-ment of varicose veins. Am J Surg. 1937, 36:389.
12. Goldman MP, et al. Sclerosing agents in the treatment of telangiectasia: Comparison of the clinical and histologic effects of intravascular polidocanol, sodium tetradecyl sulfate, and hypertonic saline in the dorsal rabbit ear vein model. Arch Dermatol. 1987, 123:1196.
13. Martin DE, Goldman MP A comparison of sclerosing agents: Clinical and histologic effects of intravascular sodium tetradecyl sulfate and chromated glycerine in the dorsal rabbit ear. J Dermatol Surg Oncol. 1990, 16:18.
14. Goldman MP A comparison of sclerosing agents: Clinical and histologic effects of intravascular sodium morrhuate, ethanolamine oleate, hyper-tonic saline (11.7%), and sclerodex in the dorsal rabbit ear vein. J Dermatol Surg Oncol. 1991, 17:354.
15. Blenkinsopp WK. Comparison of tetradecyl sulfate of sodium with other.
16. Hamel-Desnos C, Desnos P, Wollmann JC, Ouvry P, Mako S Allaert FA Evaluation of the efficacy of polidocanol in the form of foam com- pared with liquid form in sclerotherapy of the greater saphenous vein: initial results. Dermatol. Surg. 2003, (29):1170-1175.
17. Hamel-Desnos C, Allaert FA, Benigni JP, Boitelle G, Chleir F, Ouvry P, et al. Etude 3/1. Mousse de Polidocanol 3% versus 1% dans la grande veine saphène. Premiers résultats, Phlébologie 2005, 58(2):165-173.
18. Wollmann JC Schaum-zwischen Vergangenheit und Zukunft. 8. Bonner Venentage 15-16. Feb. Vasomed 2002, 16(1):34-35.
19. Sadick N. Treatment of varicose and telangiectatic leg veins with hyper- tonic saline: A comparative study of heparin and saline, J Dermatol Surg Oncol.
20. Bodian EL. Sclerotherapy. Semin Dermatol. 1987, 6:238.
21. Pereira F, Pereira C, Lacerda MH Contact dermatitis due to a cream con-taining chitin and a carbitol. Contract Dermatitis. 1998, 38:290-291.
22. Dawson TA, Black RJ, Strang WC, et al. Delayed and immediate hyper-sensitivity to carbitols. Contact Dermatitis. 1989, 21:52.
23. Goldman MP Sodium tetradecyl sulfate for sclerotherapy treatment of veins: Is compounding pharmacy solution safe?. Dermatol Surg. 2004, 30:1454-1456.
24. Sadick NS, Farber B A microbiologic study of diluted sclerotherapy solu-tions. J Dermatol Surg Oncol. 1993, 19:450.
25. Goldman MP Treatment of varicose and telangiectatic leg veins: Double blind prospective comparative trial between aethoxysklerol and sotrade-col. Dermatol Surg. 2002, 28:52-55.
26. Guex JJ Indications for the sclerosing agent Polidocanol ®. J Dermatol Surg Oncol. 1993, 19:959-961.
27. Wollmann JC The history of sclerosing foams. Dermatol Surg. 2004, 30:694-703.
28. Cabrera J, Cabrera Garcia-Olmedo Nuevo metodo de esclerosis en las varicas lares, Patol Vasc 1995, 4:55-73.
29. Monfreux A Traitement sclérosant des troncs saphéniens et leurs collaté- rales par la méthode MUS, Phlébologie 1997, 50:351-353.
30. Guex JJ Foam sclerotherapy: An overview of use for primary venous insufficiency. Semin Vasc Surg. 2005, 18:25-29.